Free Trial

20 Stocks Wall Street Analysts Love the Most - 9 of 20

 
 

AptarGroup (NYSE:ATR)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$195.00 (17.1% Upside)

About AptarGroup

AptarGroup logoAptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/28/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $185.00
10/16/2024Dbs BankUpgradeHold ➝ Strong-Buy
10/15/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$168.00 ➝ $185.00
10/14/2024Jefferies Financial GroupUpgradeHold ➝ Buy$155.00 ➝ $215.00
7/17/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$163.00 ➝ $168.00
4/29/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$160.00 ➝ $163.00
4/29/2024William BlairUpgradeMarket Perform ➝ Outperform
4/29/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$150.00 ➝ $170.00
3/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$157.00 ➝ $160.00
1/3/2024Robert W. BairdUpgradeNeutral ➝ Outperform$125.00 ➝ $150.00
 

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide